SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-045643
Filing Date
2011-08-11
Accepted
2011-08-11 16:02:33
Documents
3
Period of Report
2011-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v231311_8k.htm 8-K 22147
2 EXHIBIT 99.1 v231311_ex99-1.htm EX-99.1 15761
3 GRAPHIC logo1.jpg GRAPHIC 11924
  Complete submission text file 0001144204-11-045643.txt   55709
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 111027786
SIC: 4731 Arrangement of Transportation of Freight & Cargo